Navigation Links
Atherotech Taps Canyons Medical Center Director, Lipidologist as Chief Medical Officer

BIRMINGHAM, Ala., July 29 /PRNewswire/ -- Michael Cobble, M.D., director of Canyons Medical Center in Sandy, Utah, has been appointed as Chief Medical Officer of Atherotech, Inc.

Cobble is a primary care physician, board-certified lipidologist and certified hypertension specialist. His responsibilities at the Birmingham-based cardiodiagnostic company will include educating the public and health care professionals about Atherotech's line of cardiometabolic tests. He'll also be responsible for furthering understanding and acceptance of the VAP(R) (Vertical Auto Profile) Cholesterol Test in advanced lipid testing.

Cobble succeeds James Ehrlich, M.D., who will continue to serve as a medical consultant to Atherotech while pursuing advocacy efforts for the early detection and prevention of heart disease.

"We are honored to have such a respected and passionate champion of cardiovascular health join our team," said Atherotech President and CEO Mike Mullen. "Dr. Cobble engages in clinical research and medical education to advance the understanding of cardiovascular disease, yet much of his time is spent in the real world of direct patient care and interaction. This constitutes a unique skill set that will be highly beneficial to Atherotech."

Cobble will maintain his role at Canyons Medical Center and continue to practice a full range of medicine, including diabetes care, cardiovascular disease, hypertension, dyslipidemia, and bipolar and mood disorders.

"I'm excited to join Atherotech with their dedication to lipid assessment and risk management," said Cobble. "Too many cardiovascular events continue to occur in 'low risk' as well as 'high risk' individuals, pointing to the fact that diagnostic testing and treatments need further research and focus. The VAP lipid test has been a powerful tool in our clinic and thousands of others for both risk assessments and treatments complementing valuable patient care."

Cobble is a member of the American Academy of Family Practice and a board member as well as secretary for the Pacific Lipid Association. He is a member of the National Lipid Association, a board-certified clinical lipidologist and fellow of the National Lipid Association. He is also a member of the American Society of Hypertension and is recognized as a clinical hypertension specialist.

Since completing medical school and residency in the early '90s, he has obtained a master's degree in psychopharmacology, and his practice is a referral clinic for the Harvard Bipolar Research Group. He lectures extensively and has published articles on topics ranging from pathophysiology and lipidology to the treatment of diabetes.

Atherotech developed and markets the VAP Cholesterol Test, available nationwide, which reports 20 separate components of blood compared to just four in the standard cholesterol test. The VAP Test has been identified by as one of "Ten Ways to Live Longer" and recognized by the Wall Street Journal as one of "Five Tests Worth Paying For."

The company also provides more than a dozen cardiovascular and metabolic testing panels, including

C-Reactive Protein (hsCRP), ApoE genotype and NT-proBNP for assessment of patients at intermediate to high risk of cardiometabolic diseases. Atherotech continues to add advanced and follow-up cardiovascular disease (CVD) risk profiles.

About Atherotech, Inc.

Atherotech is a cardio-diagnostic company focusing on cardiometabolic tests, including the company's patented VAP Cholesterol Test, which reports the cholesterol content of all lipids, components and subclasses. The VAP Test is the first cholesterol profile to comply with updated National Cholesterol Education Program ATP III recommendations for direct LDL measurement, which is accurate with non-fasting samples. It is the only advanced lipid profile that routinely reports all three lipoprotein parameters considered necessary by the American Diabetes Association and American College of Cardiology expert consensus guidelines. The VAP Test is available through national and regional diagnostic laboratories and is reimbursed by many of the largest private insurers as well as Medicare. For more information, visit

SOURCE Atherotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy
2. VAP Cholesterol Test From Atherotech Covers 90 Percent of Arizona Insured
3. Atherotech to Exhibit the VAP Test (R) at ACC 2008 Meeting in Chicago
4. Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients
5. Atherotech to Exhibit the VAP Test at Internal Medicine 2008
6. VAP(R) Cholesterol Test From Atherotech Covers an Additional 9 Million of Florida Insured
7. Atherotech to Exhibit VAP(R) Cholesterol Test at American Heart Association Scientific Sessions 2008
8. Atherotech Announces Addition of ApoAI Heart Disease, Diabetes Risk Marker to VAP(R) Test
9. Atherotech to Exhibit the VAP(R) Cholesterol Test at ACC.09 in Orlando
10. Atherotech Unveils New Cardiometabolic Test Panels
11. Atherotech to Exhibit its VAP(R) Cholesterol Test at Internal Medicine 2009 in Philadelphia
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... be speaking at the following conference, and invited investors ... York, NY      Tuesday, December 1, 2015 at ... York, NY      Tuesday, December 1, 2015 at ... Healthcare Conference, New York, NY ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... on behalf of the Toronto Stock Exchange, confirms that ... are no corporate developments that would cause the recent ... --> --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical ...
(Date:11/24/2015)... 24, 2015 SHPG ) announced today that ... Piper Jaffray 27 th Annual Healthcare Conference in ... at 8:30 a.m. EST (1:30 p.m. GMT). --> SHPG ... will participate in the Piper Jaffray 27 th Annual Healthcare ... Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). ...
(Date:11/24/2015)... ... November 24, 2015 , ... In harsh ... Insertion points for in-line sensors can represent a weak spot where leaking process ... series of retractable sensor housings , which are designed to tolerate extreme process ...
Breaking Biology Technology:
(Date:10/29/2015)... , October 29, 2015 ... biometric authentication company focused on the growing mobile ... wallet announces that StackCommerce, a leading marketplace to ... featuring the Wocket® smart wallet on StackSocial for ... ) ("NXT-ID" or the "Company"), a biometric authentication ...
(Date:10/27/2015)... , Oct. 27, 2015 In the present ... of concern for various industry verticals such as banking, ... to the growing demand for secure & simplified access ... ,sectors, such as hacking of bank accounts, misuse of ... equipment such as PC,s, laptops, and smartphones are expected ...
(Date:10/27/2015)... SAN JOSE, Calif. , Oct. 27, 2015 /PRNewswire/ ... human interface solutions, today announced that Google has adopted ... family of touch controller solutions to power its newest ... Nexus 6P by Huawei. --> ... ecosystem partners like Google to provide strategic collaboration in ...
Breaking Biology News(10 mins):